Insider · CIK 0001934689
Karen DeHaan-Fullerton
Files at ZOMDF (Zomedica Corp.). First filing May 20, 2025, latest May 20, 2025.
Karen DeHaan-Fullerton files SEC Form 4 as officer at ZOMDF (Zomedica Corp.). Since May 20, 2025, Karen DeHaan-Fullerton has reported 1 open-market buy worth $5,006 and 0 open-market sells worth $0, the latest filed on May 20, 2025.
A track record needs three past buys with six months of prices behind them; Karen DeHaan-Fullerton has 0, so none is measured yet.
The newest scored trade: bought $5,006 of ZOMDF on May 19, 2025, filed May 20, 2025, scored 46 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZOMDF: Zomedica Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Zomedica Corp. | $5,006 104,300 shares | - | +57% from low-68% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | ZOMDF Zomedica Corp. | AGrant or award Options to buy Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Jun 16, 2025 |
| May 19, 2025 | ZOMDF Zomedica Corp. | POpen-market purchase Common Stock, without par value | +104,300 | $0.05 | $5,006 | 104,300 | May 20, 2025 |
| Nov 11, 2024 | ZOMDF Zomedica Corp. | AGrant or award Options to Buy Common Stockderivative | +500,000 | $0.00 | $0 | 500,000 | Nov 13, 2024 |
Questions about Karen DeHaan-Fullerton
Answered from the filings on this page, as of the latest one.
Is Karen DeHaan-Fullerton buying or selling?
Not in the last 12 months. Karen DeHaan-Fullerton's latest open-market trade on SEC Form 4 was bought $5,006 of ZOMDF on May 19, 2025.
How did Karen DeHaan-Fullerton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karen DeHaan-Fullerton has 0.
Where does Karen DeHaan-Fullerton file Form 4?
Karen DeHaan-Fullerton has filed Form 4 at ZOMDF (Zomedica Corp.) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.